Notable Analyst Rating Changes 2/14: BIDU, VCLK, CHK Upgraded; LVLT, NHWK, IM Downgraded
More News related to AGN
- Allergan (AGN) Receives FDA Approval for OZURDEX(TM)
- Allergan Receives FDA Approval for OZURDEX(TM) Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
- Sanofi-Aventis (SNY) On the Prowl For A Mega-Deal In the U.S.?
- SunTrust Initiates Coverage on Several Drug Manufacturers & Suppliers
- Oceana Therapeutics Completes Transaction for Rights to Deflux and Solesta; Company Achieves Key Growth Milestone Despite Challenging Economic Environment
More News related to BIDU
- Deutsche Bank Boosts Price Target On Baidu.com (BIDU) to $374
- Susquehanna Boosts Price Target on Baidu.com (BIDU) to $350
- Notable Analyst Rating Changes 6/19: CCL, ARM, SPWRA, FRO Upgraded; VMW, LDK, RFMD Downgraded
- HSBC Starts Bearish Coverage on Baidu.com (BIDU)
- Goldman Sachs Boosted Its Price Target on Baidu (BIDU) to $350
More News related to CHK
- Chesapeake Energy (CHK) COO Enters 10b5-1 Stock Trading Plan
- Chesapeake Energy CEO Says Increased Use of Natural Gas Would Benefit Environment and Economy, an Industrial Info News Alert
- Chesapeake Energy (CHK) Declares Qtr. Dividend of $0.075, Yielding 1.31%
- Chesapeake Energy Corporation Declares Quarterly Common and Preferred Stock Dividends and Completes Mandatory Conversion of 6.25% Preferred Stock
- Morgan Stanley Private Equity and Triana Energy Announce Second Partnership
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
RBC Capital upgrades Baidu.com (Nasdaq: BIDU) from Sector Perform to Outperform. Price target lowered from $400 to $361.
Baird and Oppenheimer upgrade ValueClick (Nasdaq: VCLK) to Outperform and Buy, respectively.
Wachovia upgrades Chesapeake Energy (NYSE: CHK) from Market Perform to Outperform.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Morgan Stanley downgrades Level 3 Communications (Nasdaq: LVLT) from Equalweight to Underweight.
Goldman Sachs downgrades NightHawk Radiology Holdings (Nasdaq: NHWK) from Buy to Neutral.
Needham & Co downgrades Ingram Micro (NYSE: IM) from Strong Buy to Buy. Price target $20.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
SunTrust Robinson Humphrey initiates coverage on Hologic (Nasdaq: HOLX) with a Buy rating and an $82 price target. The firm called Hologic a "best in class company" and the "premier women's health company".
Bear Stearns initiates coverage on Allergan (NYSE: AGN) with a Peer Perform.
Morgan Joseph initiates coverage on 1-800-Flowers.Com (Nasdaq: FLWS) with a Buy rating and $13 price target. The firm expects continued margin improvement.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-21.23
+9.08Related Entities
- Goldman Sachs
- Morgan Stanley
- Bear Stearns
- Wachovia
- Robert W Baird
- Needham & Co
- RBC Capital
- Morgan Joseph
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
